Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

11 Jul 2012 07:00

RNS Number : 3769H
Charlemagne Capital Limited
11 July 2012
 



11 July 2012

 

 

Interim Management Statement for the Six Months Ended 30 June 2012

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year.It is expected that the interim financial results will be announced on 18 September 2012.

 

Key highlights and Group AuM

 

§ As at 30 June 2012, Group AuM were US$2.3 billion, down by 2.2% since 1 January 2012;

 

§ Net management fees of US$9.7 million, down 7.6% on the previous six months; and

 

·; The Group remains well-capitalised with a strong and liquid balance sheet.

 

The table below sets out the Group's AuM as at 30 June 2012 and the movements experienced in each product range in the period since 1 January 2012.

 

 

 

01-Jan-12

Net Subscriptions

Net Performance

30-Jun-12

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

260

39

15.0

7

2.5

306

17.7

OCCO

444

50

11.3

18

3.8

512

15.3

Institutional

1,452

(229)

(15.8)

79

5.9

1,302

(10.3)

Specialist

172

(10)

(5.8)

(5)

(3.0)

157

(8.7)

Total

2,328

(150)

(6.4)

99

4.4

2,277

(2.2)

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2012

 

Net management fees receivable were US$9.7 million compared with US$10.5 million for the previous six months and US$12.1 million for the comparable period of 2011, reflecting the lower average AuM offset in part by an increase in net margin in the first half of 2012.

 

Crystallised performance fees were US$0.9 million compared with US$0.1 million for the comparative period in 2011.

 

Accruing performance fees1 for 2012 which have not crystallised were US$3.5 million compared with US$1.5 million as at the same date in 2011.

 

 

 

 

____________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Summary

 

After a strong opening two months of the year, emerging markets softened over the remainder of the first half, as macroeconomic data from most major economies of the world came below expectations. This in turn increases the likelihood that earnings forecasts, both in developed and emerging economies will be revised downwards, although valuations in the emerging markets already appear to have discounted this outcome. Oil importing Turkey, whose market rose 28% over the six months in US$, was one of the best performers, while amongst the larger markets Brazil lagged, with a decline of 8%.

 

Over the period, the relative performance of Charlemagne's equity strategies was strong, with six of the eight Magna sub-funds in the top half of their FactSet Morningstar peer group comparisons and none in the bottom quartile.

 

There have been positive net inflows into the Magna funds over the first half of the year particularly into the Latin American and GEMs Dividend strategies. Institutional mandates experienced outflows mainly in the first quarter which was partially offset in the second quarter with the acquisition of a new US$130 million institutional Latin American mandate. The OCCO Eastern European Fund reopened during the period and the US$120 million new capacity has been fully allocated with US$70 million still to be invested in the third quarter. The fund has therefore been closed once again to new investors.

 

The trading environment remains challenging, with markets volatile, investor confidence fragile and fund flows subdued. The Group has negotiated these conditions well; achieving the key objective of making money for our investors, but overall reduced asset values has had a direct impact on group revenues. We have continued to improve operational efficiency and to take action on costs, where such measures are not to the detriment of delivering investment performance for clients, but market values will need to rise in order for the group to see meaningful levels of profitability from recurring fee sources.

 

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

 

 

Singer Capital Markets Ltd

+44 203 205 7500

Jonny Franklin-Adams

 

 

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

Ged Brumby

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMNNGZGZZM
Date   Source Headline
14th Jan 20147:00 amRNSTrading Statement
11th Oct 20133:28 pmRNSQ3 2013 AUM Update
17th Sep 20139:52 amRNSDividend Declaration
17th Sep 20137:00 amRNSHalf Yearly Report
10th Sep 20134:59 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Aug 20136:08 pmRNSNotification of Significant Shareholding
12th Jul 20137:00 amRNSInterim Management Statement
8th Jul 20136:03 pmRNSNotification of Significant Shareholding
25th Jun 201310:14 amRNSChange in Significant Interest
20th Jun 201312:02 pmRNSChange in Significant Shareholding
13th Jun 201312:40 pmRNSResult of AGM
20th May 20134:49 pmRNSAnnual Report and Notice of AGM
26th Mar 20139:00 amRNSDividend Declaration
26th Mar 20137:00 amRNSFinal Results
6th Feb 20134:40 pmRNSSecond Price Monitoring Extn
6th Feb 20134:35 pmRNSPrice Monitoring Extension
23rd Jan 20134:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20134:35 pmRNSPrice Monitoring Extension
22nd Jan 20137:00 amRNSAppointment of Sole Broker
21st Jan 20139:34 amRNSNotification of Major Interest in Shares
5th Nov 20127:00 amRNSAdviser Change of Name
11th Oct 201210:15 amRNSSignificant Shareholding Announcement
10th Oct 20129:46 amRNSQ3 2012 AUM Update (Replacement)
10th Oct 20127:00 amRNSQ3 2012 AUM Update
18th Sep 20127:00 amRNSResults for the six months to 30 June 2012
11th Jul 20127:00 amRNSInterim Management Statement
27th Jun 201211:14 amRNSDirector Declaration
14th Jun 20123:21 pmRNSAGM Statement
10th May 20129:58 amRNSNotice of AGM
4th May 20122:00 pmRNSDirector/PDMR Shareholding
27th Apr 201212:58 pmRNSEuropean Convergence Development Company PLC
5th Apr 20124:04 pmRNSDirector/PDMR Shareholding
5th Apr 20127:00 amRNSAUM update
29th Mar 20125:59 pmRNSDirectors Dealings
29th Mar 20127:00 amRNSDirector/PDMR Shareholding
20th Mar 20128:15 amRNSDividend Declaration
20th Mar 20127:00 amRNSFinal Results
12th Jan 20127:00 amRNSTrading Statement
7th Oct 20117:00 amRNSAssets under Management
30th Sep 201112:41 pmRNSNotification of Major Interest in Shares
23rd Sep 20113:46 pmRNSSignificant Shareholding
24th Aug 20117:00 amRNSSignificant Shareholding
5th Aug 20114:40 pmRNSSecond Price Monitoring Extn
5th Aug 20114:35 pmRNSPrice Monitoring Extension
7th Jul 20117:00 amRNSTrading Statement
5th Jul 201111:54 amRNSChange to Significant Shareholding
10th Jun 20117:00 amRNSBusiness Update Announcement
25th May 20114:40 pmRNSSecond Price Monitoring Extn
25th May 20114:35 pmRNSPrice Monitoring Extension
13th May 201112:36 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.